Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Deferred Tax Assets: 2020-2023

Historic Current Deferred Tax Assets for ADC Therapeutics (ADCT) over the last 1 years, with Sep 2023 value amounting to $73,102.

  • ADC Therapeutics' Current Deferred Tax Assets was N/A to $73,102 in Q3 2023 from the same period last year, while for Sep 2023 it was $73,102, marking a year-over-year change of. This contributed to the annual value of $218,002 for FY2021, which is N/A change from last year.
  • Per ADC Therapeutics' latest filing, its Current Deferred Tax Assets stood at $73,102 for Q3 2023, which was down 2.53% from $75,000 recorded in Q2 2023.
  • ADC Therapeutics' Current Deferred Tax Assets' 5-year high stood at $1.6 million during Q2 2020, with a 5-year trough of $73,102 in Q3 2023.
  • Its 2-year average for Current Deferred Tax Assets is $146,671, with a median of $148,000 in 2021.
  • Data for ADC Therapeutics' Current Deferred Tax Assets shows a maximum YoY slumped of 90.58% (in 2021) over the last 5 years.
  • Over the past 3 years, ADC Therapeutics' Current Deferred Tax Assets (Quarterly) stood at $1.6 million in 2020, then tumbled by 86.04% to $218,002 in 2021, then reached $73,102 in 2023.
  • Its Current Deferred Tax Assets was $73,102 in Q3 2023, compared to $75,000 in Q2 2023 and $218,002 in Q4 2021.